DELFI Diagnostics logo

DELFI Diagnostics

DELFI's AI and whole-genome sequencing platform detects cancer-associated cfDNA fragmentation patterns in the blood.

153 employees · est. 2019 · Palo Alto, United States

VS
hyprfire logo

hyprfire

Your critical network cyber security events, delivered to you. 🔥 Award-winning. Quiet, actionable, fast, affordable.

10 employees · est. 2020 · Australia

DELFI Diagnostics is the older company (2019 vs 2020); DELFI Diagnostics is the larger of the two.

Side-by-Side Comparison

DELFI Diagnostics hyprfire
Founded
2019 older 2020
Headquarters
Palo Alto, United States Australia
Employees
153 larger 10
Industry
AI, Biotechnology, Health Care Cyber Security, Information Technology
Funding Stage
Series B Not tracked yet
Total Funding
$330.50M Not tracked yet
Funding Rounds
3 Not tracked yet
Services
Cancer Detection Solutions, Liquid Biopsy Diagnostics, Clinical Trial Services, Research and Innovation in Fragmentomics, Machine Learning Application in Genomic Sequencing Managed Network Detection and Response
Target Customers
Healthcare Providers, Patients, Pharmaceutical Companies, Biotech Researchers, Hospital Systems Businesses seeking enhanced network security and threat detection capabilities
Taxonomy
Cancer Detection, Early Detection, Genome Sequencing, DNA Fragmentation, Medical Technology, Healthcare Innovation Cyber Security, Network Detection, Threat Hunting, Ransomware Detection, Incident Response, Managed Network Solution, Lateral Movement Detection, Insider Threat Detection, Exfiltration Detection, Cyber Forensics, Network Visibility, Network Monitoring
Website
delfidiagnostics.com hyprfire.com
DELFI Diagnostics logo

About DELFI Diagnostics

DELFI Diagnostics, founded in 2019, is at the forefront of the convergence of AI and biotechnology, focusing on health care through early cancer detection. Their slogan, "Saving lives through early cancer detection," encapsulates their mission of leveraging artificial intelligence and whole genome s...

hyprfire logo

About hyprfire

Hyprfire is an Australian startup that offers a Managed Network Detection and Response solution, Firebug, designed for IT teams with limited cyber resources. The company's aim is to provide active monitoring for abnormal behavior on networks, serving as an early warning system. Their solution is lab...

We will tell you when either one moves

BounceWatch watches DELFI Diagnostics and hyprfire for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at DELFI Diagnostics and hyprfire — by email.

Frequently Asked Questions

DELFI Diagnostics — DELFI's AI and whole-genome sequencing platform detects cancer-associated cfDNA fragmentation patterns in the blood.. hyprfire — Your critical network cyber security events, delivered to you. 🔥 Award-winning. Quiet, actionable, fast, affordable. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
DELFI Diagnostics has raised $330.50M while hyprfire has raised undisclosed funding.
DELFI Diagnostics and hyprfire operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare DELFI Diagnostics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at DELFI Diagnostics on 9 Jun 2026, and hyprfire on 3 Mar 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy